NCT03952364View on ClinicalTrials.gov

The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Crohn DiseaseUlcerative ColitisIBDInflammatory Bowel Diseases
Interventions
OTHER

PredictSURE IBD™

To evaluate a test called PredictSURE IBD™ in the US population

Trial Locations (8)

10016

RECRUITING

Manhattan Clinical Research, LLC., New York

RECRUITING

NYU Langone Health, New York

10065

RECRUITING

Weill Cornell Medical Center, New York

33136

RECRUITING

University of Miami Crohn's and Colitis Center, Miami

37421

RECRUITING

ClinSearch, Chattanooga

63130

RECRUITING

Washington University in St. Louis, St Louis

08901

RECRUITING

Rutgers Robert Wood Johnson Medical School (Adult), New Brunswick

RECRUITING

Rutgers Robert Wood Johnson Medical School (Prediatric), New Brunswick

Sponsors

Lead Sponsor

PredictImmune Ltd
All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

lead

PredictImmune Ltd

INDUSTRY